Invited Speakers

Prof. Dr. Besim Ogretmen Medical University of South Carolina - United States Sphingolipid Metabolism and Signaling in Cancer Therapy: Implications in Aging, Neurodegeneration, and Immunotherapy
Assoc. Prof. Atil Bisgin Cukurova University - Turkey Liquid Biopsy and Multi-Omics Approach in Clinical Practice
Baris Korkmaz, PhD INSERM , France Cathepsin C as Pharmacological Target in Cancer
Bruno Sainz, PhD Autonomous University of Madrid - Spain Cancer Stem Cells and Tumor Microenvironment
Prof. Dr. Fahri Saatcioglu University of Oslo - Norway Unfolded Protein Response Drives Prostate Cancer
Asst. Prof. Farasat Zaman Karolinska University - Sweeden Bone Growth Disorders in Childhood Cancer
Prof. Dr. Gamze Tanriover Akdeniz University - Turkey Stopping the Fast Moving Carcinogenesis with the Brakes of Rottlerin
Prof. Dr . Gülinnaz Ercan Ege University - Turkey Anti-Cancer Efficiency of Natural Killer Cells Differentiated from Different Human Multipotent Stem Cells
Prof. Dr. Hana Algul Munich Technical University - Germany Precision Medicine in Pancreatic Cancer
PD Dr. Dr. Ihsan Ekin Demir Technical University of Munich - Germany Organoid Models of Neuronal Invasion of in Cancer
Prof. Dr. Janko Kos University of Ljubljana - Slovenia Regulation of NK Cells and CTL in Tumor Microenvironment by Cysteine Cathepsins
Prof. Dr. Jordi Camps Autonomous University of Barcelona - Spain Tetraploidy-Associated Intratumor Heterogeneity Promotes Initiation and Progression of Colorectal Cancer
Maurizio Callari, PhD University of Cambridge - UK Mass Cytometry Reveals Complex Cellular Phenotypic Diversity in Breast Cancer Xenografts
Assoc. Prof. Mazhar Adli, PhD Northwestern University - United States Understanding and Targeting Genome Regulation with CRISPR
Assoc. Prof. Ozgur Kutuk Baskent University - Turkey Kinome-wide RNAi Screening for Mediators of ABT-199 Resistance in Breast Cancer Cells Identifies Wee1 as a Novel Therapeutic Target
Assoc. Prof. Ozgur Sahin University of South Carolina - United States From Mechanisms of Drug Resistance to Drug Discovery
Assoc. Prof. Sehime Temel Uludag University - Turkey Liquid Biopsy Experiences and Fusion Detections an Overview of Bursa Uludag Genetics Lab Experience
Bogazici Uni Panel
Asst. Prof. Tolga Sütlü Bogazici University - Turkey Preclinical Development of Personalized Cancer Immunotherapies Using Natural Killer Cells
Prof. Dr. Batu Erman Bogazici University - Turkey Structural and Functional Analysis of the Transcription Factor Patz1: Implications for Ewing's Sarcoma
Assoc. Prof. Dr. Tolga Emre Bogazici University - Turkey Cancer Epigenetics and IRF4
Prof. Dr. Nesrin Özören Bogazici University - Turkey NLRP7 in Molar Pregnancy Disease and Cancers
Koç Uni All Woman Panel
Buse Cevatemre, PhD Koc University - Turkey Drug library screening identifies epigenetic modifiers that revert taxane resistance in prostate cancer
Ceyda Acilan, PhD Koc University - Turkey How does prostate cancer become taxane resistant? An omics approach
Asst. Prof. Gülnihal Özcan Koc University - Turkey Time and order to transform antagonism into synergism for drug combinations in gastric cancer
Assoc. Prof. Tuğba Bağcı Önder Koc University - Turkey CRISPR/Cas9-based identification of epigenetic factors that will overcome therapy resistance in cancers